Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/5444Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lahari Sidde | - |
| dc.date.accessioned | 2026-06-27T08:26:59Z | - |
| dc.date.available | 2026-06-27T08:26:59Z | - |
| dc.date.issued | 2026-06-27 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/5444 | - |
| dc.description | Vol. 35, No. 2, p 369 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Anti-breast cancer | en_US |
| dc.subject | Cell lines | en_US |
| dc.subject | In vitro | en_US |
| dc.subject | In vivo models | en_US |
| dc.subject | Signaling pathway | en_US |
| dc.subject | Syntheretic drugs | en_US |
| dc.title | Advances in heterocyclic compounds for breast cancer treatment : A compreshensive review | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol. 35, No. 2, 2025 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.